Global Human Cytomegalovirus Envelope Glycoprotein B Market Size, Share, Trends and Forecast 2021-2027

Description

The global Human Cytomegalovirus Envelope Glycoprotein B market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
Global Human Cytomegalovirus Envelope Glycoprotein B Scope and Segment
Human Cytomegalovirus Envelope Glycoprotein B market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Human Cytomegalovirus Envelope Glycoprotein B market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2016-2027.
The following manufacturers are covered in this report:
Astellas Pharma Inc.
Trellis Bioscience, Inc.
Vakzine Projekt Management GmbH
VBI Vaccine Inc
Vical Incorporated
Human Cytomegalovirus Envelope Glycoprotein B Breakdown Data by Type
CSJ-148
CyMVectin
TRL-345
PPCM
Cytomegalovirus Vaccine
Others
Human Cytomegalovirus Envelope Glycoprotein B Breakdown Data by Application
Infectious Disease
Oncology
Women's Health
Others
Regional and Country-level Analysis
The Human Cytomegalovirus Envelope Glycoprotein B market is analysed and market size information is provided by regions (countries).
The key regions covered in the Human Cytomegalovirus Envelope Glycoprotein B market report are North America, Europe, China and Japan. It also covers key regions (countries), viz, the U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2016-2027. It also includes market size and forecast by Type, and by Application segment in terms of production capacity, price and revenue for the period 2016-2027.
Competitive Landscape and Human Cytomegalovirus Envelope Glycoprotein B Market Share Analysis

TABLE OF CONTENT

1 Study Coverage
1.1 Human Cytomegalovirus Envelope Glycoprotein B Product Introduction
1.2 Market by Type
1.2.1 Global Human Cytomegalovirus Envelope Glycoprotein B Market Size Growth Rate by Type
1.4.2 CSJ-148
1.4.3 CyMVectin
1.2.4 TRL-345
1.2.5 PPCM
1.2.6 Cytomegalovirus Vaccine
1.2.7 Others
1.3 Market by Application
1.3.1 Global Human Cytomegalovirus Envelope Glycoprotein B Market Size Growth Rate by Application
1.3.2 Infectious Disease
1.3.3 Oncology
1.3.4 Women's Health
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered

2 Executive Summary
2.1 Global Human Cytomegalovirus Envelope Glycoprotein B Sales Estimates and Forecasts 2016-2027
2.2 Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Estimates and Forecasts 2016-2027
2.3 Global Human Cytomegalovirus Envelope Glycoprotein B Revenue by Region: 2016 VS 2021 VS 2027
2.4 Global Top Human Cytomegalovirus Envelope Glycoprotein B Regions by Sales
2.4.1 Global Top Human Cytomegalovirus Envelope Glycoprotein B Regions by Sales (2016-2021)
2.4.2 Global Top Human Cytomegalovirus Envelope Glycoprotein B Regions by Sales (2022-2027)
2.5 Global Top Human Cytomegalovirus Envelope Glycoprotein B Regions by Revenue
2.5.1 Global Top Human Cytomegalovirus Envelope Glycoprotein B Regions by Revenue (2016-2021)
2.5.2 Global Top Human Cytomegalovirus Envelope Glycoprotein B Regions by Revenue (2022-2027)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Human Cytomegalovirus Envelope Glycoprotein B Sales by Manufacturers
3.1.1 Global Top Human Cytomegalovirus Envelope Glycoprotein B Manufacturers by Sales (2016-2021)
3.1.2 Global Top Human Cytomegalovirus Envelope Glycoprotein B Manufacturers Market Share by Sales (2016-2021)
3.1.3 Global Top 10 and Top 5 Companies by Human Cytomegalovirus Envelope Glycoprotein B Sales in 2020
3.2 Global Human Cytomegalovirus Envelope Glycoprotein B Revenue by Manufacturers
3.2.1 Global Top Human Cytomegalovirus Envelope Glycoprotein B Manufacturers by Revenue (2016-2021)
3.2.2 Global Top Human Cytomegalovirus Envelope Glycoprotein B Manufacturers Market Share by Revenue (2016-2021)
3.2.3 Global Top 10 and Top 5 Companies by Human Cytomegalovirus Envelope Glycoprotein B Revenue in 2020
3.3 Global Human Cytomegalovirus Envelope Glycoprotein B Sales Price by Manufacturers
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Human Cytomegalovirus Envelope Glycoprotein B Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Human Cytomegalovirus Envelope Glycoprotein B Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Global Human Cytomegalovirus Envelope Glycoprotein B Sales by Type
4.1.1 Global Human Cytomegalovirus Envelope Glycoprotein B Historical Sales by Type (2016-2021)
4.1.2 Global Human Cytomegalovirus Envelope Glycoprotein B Forecasted Sales by Type (2022-2027)
4.1.3 Global Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Type (2016-2027)
4.2 Global Human Cytomegalovirus Envelope Glycoprotein B Revenue by Type
4.2.1 Global Human Cytomegalovirus Envelope Glycoprotein B Historical Revenue by Type (2016-2021)
4.2.2 Global Human Cytomegalovirus Envelope Glycoprotein B Forecasted Revenue by Type (2022-2027)
4.2.3 Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Type (2016-2027)
4.3 Global Human Cytomegalovirus Envelope Glycoprotein B Price by Type
4.3.1 Global Human Cytomegalovirus Envelope Glycoprotein B Price by Type (2016-2021)
4.3.2 Global Human Cytomegalovirus Envelope Glycoprotein B Price Forecast by Type (2022-2027)
5 Market Size by Application
5.1 Global Human Cytomegalovirus Envelope Glycoprotein B Sales by Application
5.1.1 Global Human Cytomegalovirus Envelope Glycoprotein B Historical Sales by Application (2016-2021)
5.1.2 Global Human Cytomegalovirus Envelope Glycoprotein B Forecasted Sales by Application (2022-2027)
5.1.3 Global Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Application (2016-2027)
5.2 Global Human Cytomegalovirus Envelope Glycoprotein B Revenue by Application
5.2.1 Global Human Cytomegalovirus Envelope Glycoprotein B Historical Revenue by Application (2016-2021)
5.2.2 Global Human Cytomegalovirus Envelope Glycoprotein B Forecasted Revenue by Application (2022-2027)
5.2.3 Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Application (2016-2027)
5.3 Global Human Cytomegalovirus Envelope Glycoprotein B Price by Application
5.3.1 Global Human Cytomegalovirus Envelope Glycoprotein B Price by Application (2016-2021)
5.3.2 Global Human Cytomegalovirus Envelope Glycoprotein B Price Forecast by Application (2022-2027)

6 North America
6.1 North America Human Cytomegalovirus Envelope Glycoprotein B Market Size by Type
6.1.1 North America Human Cytomegalovirus Envelope Glycoprotein B Sales by Type (2016-2027)
6.1.2 North America Human Cytomegalovirus Envelope Glycoprotein B Revenue by Type (2016-2027)
6.2 North America Human Cytomegalovirus Envelope Glycoprotein B Market Size by Application
6.2.1 North America Human Cytomegalovirus Envelope Glycoprotein B Sales by Application (2016-2027)
6.2.2 North America Human Cytomegalovirus Envelope Glycoprotein B Revenue by Application (2016-2027)
6.3 North America Human Cytomegalovirus Envelope Glycoprotein B Market Size by Country
6.3.1 North America Human Cytomegalovirus Envelope Glycoprotein B Sales by Country (2016-2027)
6.3.2 North America Human Cytomegalovirus Envelope Glycoprotein B Revenue by Country (2016-2027)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Human Cytomegalovirus Envelope Glycoprotein B Market Size by Type
7.1.1 Europe Human Cytomegalovirus Envelope Glycoprotein B Sales by Type (2017-2027)
7.1.2 Europe Human Cytomegalovirus Envelope Glycoprotein B Revenue by Type (2017-2027)
7.2 Europe Human Cytomegalovirus Envelope Glycoprotein B Market Size by Application
7.2.1 Europe Human Cytomegalovirus Envelope Glycoprotein B Sales by Application (2017-2027)
7.2.2 Europe Human Cytomegalovirus Envelope Glycoprotein B Revenue by Application (2017-2027)
7.3 Europe Human Cytomegalovirus Envelope Glycoprotein B Market Size by Country
7.3.1 Europe Human Cytomegalovirus Envelope Glycoprotein B Sales by Country (2017-2027)
7.3.2 Europe Human Cytomegalovirus Envelope Glycoprotein B Revenue by Country (2017-2027)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Human Cytomegalovirus Envelope Glycoprotein B Market Size by Type
8.1.1 Asia Pacific Human Cytomegalovirus Envelope Glycoprotein B Sales by Type (2018-2027)
8.1.2 Asia Pacific Human Cytomegalovirus Envelope Glycoprotein B Revenue by Type (2018-2027)
8.2 Asia Pacific Human Cytomegalovirus Envelope Glycoprotein B Market Size by Application
8.2.1 Asia Pacific Human Cytomegalovirus Envelope Glycoprotein B Sales by Application (2018-2027)
8.2.2 Asia Pacific Human Cytomegalovirus Envelope Glycoprotein B Revenue by Application (2018-2027)
8.3 Asia Pacific Human Cytomegalovirus Envelope Glycoprotein B Market Size by Region
8.3.1 Asia Pacific Human Cytomegalovirus Envelope Glycoprotein B Sales by Region (2018-2027)
8.3.2 Asia Pacific Human Cytomegalovirus Envelope Glycoprotein B Revenue by Region (2018-2027)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Human Cytomegalovirus Envelope Glycoprotein B Market Size by Type
9.1.1 Latin America Human Cytomegalovirus Envelope Glycoprotein B Sales by Type (2019-2027)
9.1.2 Latin America Human Cytomegalovirus Envelope Glycoprotein B Revenue by Type (2019-2027)
9.2 Latin America Human Cytomegalovirus Envelope Glycoprotein B Market Size by Application
9.2.1 Latin America Human Cytomegalovirus Envelope Glycoprotein B Sales by Application (2019-2027)
9.2.2 Latin America Human Cytomegalovirus Envelope Glycoprotein B Revenue by Application (2019-2027)
9.3 Latin America Human Cytomegalovirus Envelope Glycoprotein B Market Size by Country
9.3.1 Latin America Human Cytomegalovirus Envelope Glycoprotein B Sales by Country (2019-2027)
9.3.2 Latin America Human Cytomegalovirus Envelope Glycoprotein B Revenue by Country (2019-2027)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
6 Middle East and Africa
6.1 Middle East and Africa Human Cytomegalovirus Envelope Glycoprotein B Market Size by Type
6.1.1 Middle East and Africa Human Cytomegalovirus Envelope Glycoprotein B Sales by Type (2016-2027)
6.1.2 Middle East and Africa Human Cytomegalovirus Envelope Glycoprotein B Revenue by Type (2016-2027)
6.2 Middle East and Africa Human Cytomegalovirus Envelope Glycoprotein B Market Size by Application
6.2.1 Middle East and Africa Human Cytomegalovirus Envelope Glycoprotein B Sales by Application (2016-2027)
6.2.2 Middle East and Africa Human Cytomegalovirus Envelope Glycoprotein B Revenue by Application (2016-2027)
6.3 Middle East and Africa Human Cytomegalovirus Envelope Glycoprotein B Market Size by Country
6.3.1 Middle East and Africa Human Cytomegalovirus Envelope Glycoprotein B Sales by Country (2016-2027)
6.3.2 Middle East and Africa Human Cytomegalovirus Envelope Glycoprotein B Revenue by Country (2016-2027)
6.3.3 Turkey
6.3.4 Saudi Arabia
6.3.5 U.A.E

11 Company Profiles
11.1 Astellas Pharma Inc.
11.1.1 Astellas Pharma Inc. Corporation Information
11.1.2 Astellas Pharma Inc. Overview
11.1.3 Astellas Pharma Inc. Human Cytomegalovirus Envelope Glycoprotein B Sales, Price, Revenue and Gross Margin (2016-2021)
11.1.4 Astellas Pharma Inc. Human Cytomegalovirus Envelope Glycoprotein B Product Description
11.1.5 Astellas Pharma Inc. Related Developments
11.2 Trellis Bioscience, Inc.
11.2.1 Trellis Bioscience, Inc. Corporation Information
11.2.2 Trellis Bioscience, Inc. Overview
11.2.3 Trellis Bioscience, Inc. Human Cytomegalovirus Envelope Glycoprotein B Sales, Price, Revenue and Gross Margin (2016-2021)
11.2.4 Trellis Bioscience, Inc. Human Cytomegalovirus Envelope Glycoprotein B Product Description
11.2.5 Trellis Bioscience, Inc. Related Developments
11.3 Vakzine Projekt Management GmbH
11.3.1 Vakzine Projekt Management GmbH Corporation Information
11.3.2 Vakzine Projekt Management GmbH Overview
11.3.3 Vakzine Projekt Management GmbH Human Cytomegalovirus Envelope Glycoprotein B Sales, Price, Revenue and Gross Margin (2016-2021)
11.3.4 Vakzine Projekt Management GmbH Human Cytomegalovirus Envelope Glycoprotein B Product Description
11.3.5 Vakzine Projekt Management GmbH Related Developments
11.4 VBI Vaccine Inc
11.4.1 VBI Vaccine Inc Corporation Information
11.4.2 VBI Vaccine Inc Overview
11.4.3 VBI Vaccine Inc Human Cytomegalovirus Envelope Glycoprotein B Sales, Price, Revenue and Gross Margin (2016-2021)
11.4.4 VBI Vaccine Inc Human Cytomegalovirus Envelope Glycoprotein B Product Description
11.4.5 VBI Vaccine Inc Related Developments
11.5 Vical Incorporated
11.5.1 Vical Incorporated Corporation Information
11.5.2 Vical Incorporated Overview
11.5.3 Vical Incorporated Human Cytomegalovirus Envelope Glycoprotein B Sales, Price, Revenue and Gross Margin (2016-2021)
11.5.4 Vical Incorporated Human Cytomegalovirus Envelope Glycoprotein B Product Description
11.5.5 Vical Incorporated Related Developments
11.1 Astellas Pharma Inc.
11.1.1 Astellas Pharma Inc. Corporation Information
11.1.2 Astellas Pharma Inc. Overview
11.1.3 Astellas Pharma Inc. Human Cytomegalovirus Envelope Glycoprotein B Sales, Price, Revenue and Gross Margin (2016-2021)
11.1.4 Astellas Pharma Inc. Human Cytomegalovirus Envelope Glycoprotein B Product Description
11.1.5 Astellas Pharma Inc. Related Developments

12 Value Chain and Sales Channels Analysis
12.1 Human Cytomegalovirus Envelope Glycoprotein B Value Chain Analysis
12.2 Human Cytomegalovirus Envelope Glycoprotein B Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Human Cytomegalovirus Envelope Glycoprotein B Production Mode & Process
12.4 Human Cytomegalovirus Envelope Glycoprotein B Sales and Marketing
12.4.1 Human Cytomegalovirus Envelope Glycoprotein B Sales Channels
12.4.2 Human Cytomegalovirus Envelope Glycoprotein B Distributors
12.5 Human Cytomegalovirus Envelope Glycoprotein B Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Human Cytomegalovirus Envelope Glycoprotein B Industry Trends
13.2 Human Cytomegalovirus Envelope Glycoprotein B Market Drivers
13.3 Human Cytomegalovirus Envelope Glycoprotein B Market Challenges
13.4 Human Cytomegalovirus Envelope Glycoprotein B Market Restraints

14 Key Findings in The Global Human Cytomegalovirus Envelope Glycoprotein B Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

Choose License Type

Checkout Inquiry Sample